Marisa Wexler, MS,  senior science writer—

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

Articles by Marisa Wexler

Phase 2 Study of Treatment for Hypoparathyroidism, TransCon PTH, Starts to Enroll Adults

A Phase 2 trial evaluating the efficacy and safety of TransCon PTH — designed to restore parathyroid hormone (PTH) levels within 24 hours — in people with hypoparathyroidism is now enrolling adults in North America and Europe. Called PaTH Forward, the study (NCT04009291) is planning to enroll about 40 patients with hypoparathyroidism who…

Fahr’s, Disease Marked by Calcium Deposits in Brain, Traced to Thyroid Surgery in Case Study

A case report of a person diagnosed with Fahr’s disease related to post-thyroidectomy hypoparathyroidism highlights the importance of doing regular screening, including brain scans and blood tests, after this surgery. “Secondary Fahr’s Disease: A Consequence of Post-Thyroidectomy Hypoparathyroidism” was published in the European Journal of Case Reports…

Calcium Supplements Not Always Needed to Treat Hypoparathyroidism, Study Suggests

A new study suggests that calcium supplements might not be necessary for all patients with hypoparathyroidism. This treatment approach could be especially helpful for patients dealing with calcium-related side effects. The study, “Is calcium supplementation always needed in patients with hypoparathyroidism?” was published in Clinical Endocrinology. Because hypoparathyroidism leads…